Symbols / CRON $2.80 +2.56% Cronos Group Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • NGM
CRON Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Fundamentals
Scroll to Statements
Market Cap 1.08B Enterprise Value 280.12M Income -9.45M Sales 146.59M Book/sh 2.87 Cash/sh 2.19
Dividend Yield — Payout 0.00% Employees 610 IPO — P/E — Forward P/E -70.00
PEG — P/S 7.35 P/B 0.98 P/C — EV/EBITDA -83.54 EV/Sales 1.91
Quick Ratio 18.45 Current Ratio 19.59 Debt/Eq 0.13 LT Debt/Eq — EPS (ttm) -0.02 EPS next Y -0.04
EPS Growth — Revenue Growth 47.00% Earnings 2026-05-11 ROA -0.90% ROE -0.26% ROIC —
Gross Margin 39.84% Oper. Margin -10.12% Profit Margin -6.44% Shs Outstand 379.05M Shs Float 197.58M Short Float 1.97%
Short Ratio 3.74 Short Interest — 52W High 3.43 52W Low 1.78 Beta 1.21 Avg Volume 1.39M
Volume 15.28M Target Price $2.30 Recom None Prev Close $2.73 Price $2.80 Change 2.56%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.30
Mean price target
2. Current target
$2.80
Latest analyst target
3. DCF / Fair value
$-2.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.80
Low
$2.30
High
$2.30
Mean
$2.30

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-05-15 main CIBC Outperformer → Outperformer $4
2024-04-08 main B of A Securities Underperform → Underperform $3
2023-12-28 main B of A Securities Underperform → Underperform $2
2023-05-15 main Barclays Equal-Weight → Equal-Weight $3
2022-11-02 init Bernstein — → Market Perform $3
2022-09-30 main Barclays — → Equal-Weight $4
2022-03-22 up Barclays Underweight → Equal-Weight —
2022-03-07 main Piper Sandler — → Neutral $3
2022-02-22 main Canaccord Genuity — → Sell $4
2022-02-22 main Piper Sandler — → Neutral $4
2022-01-27 up Jefferies Underperform → Hold $3
2021-11-18 init Barclays — → Underweight $6
2020-04-14 down Piper Sandler Overweight → Neutral —
2020-03-31 down Canaccord Genuity Hold → Sell —
2019-11-13 main B of A Securities — → Buy $15
2019-10-22 main Piper Sandler — → Overweight $12
2019-08-13 init Piper Sandler — → Overweight $18
2019-08-09 up Canaccord Genuity Sell → Hold $17
2019-06-28 init Consumer Edge Research — → Equal-Weight —
2019-06-06 init Stifel — → Hold —
News
RSS: Latest CRON news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-19 Shlimak (Anna) Senior Officer of Issuer — 28,429 — —
2026-03-19 Shlimak (Anna) Senior Officer of Issuer — 9,767 $2.54 $24,808
2026-03-15 Buggy (Shannon) Senior Officer of Issuer — 20,938 — —
2026-03-15 Buggy (Shannon) Senior Officer of Issuer — 9,202 $2.50 $23,005
2026-03-15 Doucet (Terrence Gregory Joseph) Senior Officer of Issuer — 23,897 — —
2026-03-15 Doucet (Terrence Gregory Joseph) Senior Officer of Issuer — 12,276 $2.51 $30,788
2026-03-15 Gorenstein (Michael Ryan) Director of Issuer — 324,540 — —
2026-03-15 Gorenstein (Michael Ryan) Director of Issuer — 127,706 $2.50 $319,265
2026-03-15 Jacobson (Jeffrey David) Senior Officer of Issuer — 59,191 — —
2026-03-15 Jacobson (Jeffrey David) Senior Officer of Issuer — 22,552 $2.50 $56,380
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
146.59
+24.63%
117.61
+34.82%
87.24
+0.57%
86.75
Operating Revenue
193.36
+19.49%
161.82
+34.55%
120.27
+10.04%
109.30
Cost Of Revenue
83.83
-9.29%
92.42
+22.68%
75.33
+5.64%
71.31
Reconciled Cost Of Revenue
71.72
-17.36%
86.78
+20.09%
72.27
+12.64%
64.16
Gross Profit
62.76
+149.06%
25.20
+111.59%
11.91
-22.85%
15.44
Operating Expense
82.26
-2.94%
84.75
-7.70%
91.82
-23.37%
119.83
Research And Development
4.45
+5.20%
4.23
-27.62%
5.84
-55.50%
13.13
Selling General And Administration
70.81
-7.82%
76.82
-5.08%
80.93
-19.65%
100.73
Selling And Marketing Expense
21.76
+0.75%
21.60
-4.84%
22.70
+25.80%
18.05
General And Administrative Expense
49.05
-11.17%
55.21
-5.18%
58.23
-29.57%
82.68
Salaries And Wages
7.05
-18.97%
8.70
-0.64%
8.76
-41.66%
15.01
Other Gand A
42.00
-9.71%
46.51
-5.98%
49.48
-26.89%
67.67
Total Expenses
166.08
-6.25%
177.16
+5.99%
167.15
-12.55%
191.14
Operating Income
-19.50
+67.26%
-59.55
+25.48%
-79.91
+23.45%
-104.39
Total Operating Income As Reported
-17.39
+77.27%
-76.53
+9.75%
-84.80
+23.90%
-111.43
EBITDA
-5.27
+89.51%
-50.21
+30.07%
-71.80
+21.33%
-91.27
Normalized EBITDA
32.08
+153.65%
-59.80
-147.15%
-24.19
+50.98%
-49.35
Reconciled Depreciation
14.23
+52.43%
9.34
+15.12%
8.11
-38.20%
13.12
EBIT
-19.50
+67.26%
-59.55
+25.48%
-79.91
+23.45%
-104.39
Total Unusual Items
-37.34
-489.70%
9.58
+120.13%
-47.61
-13.57%
-41.92
Total Unusual Items Excluding Goodwill
-37.34
-489.70%
9.58
+120.13%
-47.61
-13.57%
-41.92
Special Income Charges
-8.30
+84.57%
-53.83
-90.62%
-28.24
+58.73%
-68.43
Impairment Of Capital Assets
0.74
-95.50%
16.35
+385.74%
3.37
-3.64%
3.49
Restructuring And Mergern Acquisition
2.04
+223.33%
0.63
-58.66%
1.52
-57.01%
3.54
Write Off
0.00
-100.00%
25.65
+9.85%
23.35
-61.97%
61.39
Net Income
-9.45
-123.00%
41.08
+155.54%
-73.96
+56.17%
-168.73
Pretax Income
-17.12
-146.79%
36.59
+149.66%
-73.67
+39.12%
-121.00
Net Non Operating Interest Income Expense
39.96
-23.18%
52.02
+1.53%
51.23
+127.57%
22.51
Interest Expense Non Operating
—
—
—
0.01
Net Interest Income
39.96
-23.18%
52.02
+1.53%
51.23
+127.57%
22.51
Interest Expense
—
—
—
0.01
Interest Income Non Operating
39.96
-23.18%
52.02
+1.53%
51.23
+127.57%
22.51
Interest Income
39.96
-23.18%
52.02
+1.53%
51.23
+127.57%
22.51
Other Income Expense
-37.59
-185.20%
44.12
+198.05%
-44.99
-14.99%
-39.13
Other Non Operating Income Expenses
-0.24
+19.93%
-0.30
-129.25%
1.03
+417.59%
-0.32
Gain On Sale Of Security
-29.04
-145.79%
63.41
+427.46%
-19.37
-173.04%
26.51
Tax Provision
-14.19
-313.01%
-3.44
-6.38%
-3.23
-109.45%
34.17
Tax Rate For Calcs
0.00
+0.00%
0.00
+242.11%
0.00
-83.27%
0.00
Tax Effect Of Unusual Items
-5.60
-489.70%
1.44
+168.87%
-2.09
+81.00%
-10.99
Net Income Including Noncontrolling Interests
-2.93
-107.32%
40.02
+153.68%
-74.55
+55.82%
-168.73
Net Income From Continuing Operation Net Minority Interest
-9.45
-123.00%
41.08
+158.81%
-69.85
+54.99%
-155.18
Net Income From Continuing And Discontinued Operation
-9.45
-123.00%
41.08
+155.54%
-73.96
+56.17%
-168.73
Net Income Continuous Operations
-2.93
-107.32%
40.02
+156.82%
-70.44
+54.61%
-155.18
Net Income Discontinuous Operations
0.00
0.00
+100.00%
-4.11
+69.65%
-13.56
Minority Interests
-6.52
-716.07%
1.06
+79.32%
0.59
0.00
Normalized Income
22.30
-32.30%
32.93
+235.36%
-24.33
+80.42%
-124.25
Net Income Common Stockholders
-9.45
-123.00%
41.08
+155.54%
-73.96
+56.17%
-168.73
Diluted EPS
-0.02
-118.18%
0.11
+157.89%
-0.19
+57.78%
-0.45
Basic EPS
-0.02
-118.18%
0.11
+157.89%
-0.19
+57.78%
-0.45
Basic Average Shares
383.47
+0.37%
382.06
+0.29%
380.96
+1.06%
376.96
Diluted Average Shares
383.47
-0.54%
385.56
+1.21%
380.96
+1.06%
376.96
Diluted NI Availto Com Stockholders
-9.45
-123.00%
41.08
+155.54%
-73.96
+56.17%
-168.73
Depreciation Amortization Depletion Income Statement
2.12
-42.75%
3.70
-26.63%
5.04
-15.47%
5.97
Depreciation And Amortization In Income Statement
2.12
-42.75%
3.70
-26.63%
5.04
-15.47%
5.97
Earnings From Equity Interest
0.00
-100.00%
34.83
+2100.51%
1.58
-49.17%
3.11
Excise Taxes
46.78
+5.81%
44.21
+33.84%
33.03
+46.46%
22.55
Gain On Sale Of PPE
-5.53
+50.62%
-11.20
0.00
0.00
Provision For Doubtful Accounts
4.88
0.00
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,197.14
+2.64%
1,166.31
+2.28%
1,140.27
-6.00%
1,213.01
Current Assets
944.09
+0.85%
936.11
+0.30%
933.31
-2.80%
960.16
Cash Cash Equivalents And Short Term Investments
831.79
-3.15%
858.80
-0.32%
861.53
-1.84%
877.72
Cash And Cash Equivalents
791.79
-7.80%
858.80
+28.32%
669.29
-12.47%
764.64
Other Short Term Investments
40.00
0.00
-100.00%
192.24
+70.01%
113.08
Receivables
57.20
+92.13%
29.77
-17.02%
35.88
-5.01%
37.77
Accounts Receivable
34.10
+120.53%
15.46
+10.57%
13.98
-39.50%
23.11
Gross Accounts Receivable
34.11
+120.49%
15.47
+10.60%
13.99
-40.05%
23.33
Allowance For Doubtful Accounts Receivable
-0.01
-28.57%
-0.01
-133.33%
-0.00
+98.63%
-0.22
Other Receivables
14.45
+188.90%
5.00
-21.15%
6.34
+92.27%
3.30
Accrued Interest Receivable
8.65
-0.41%
8.69
-13.20%
10.01
+305.51%
2.47
Loans Receivable
0.00
-100.00%
0.62
-88.85%
5.54
-37.67%
8.89
Inventory
46.75
+41.03%
33.15
+8.70%
30.50
-18.81%
37.56
Raw Materials
8.91
+60.48%
5.55
+9.21%
5.08
-39.56%
8.41
Work In Process
25.83
+80.00%
14.35
+35.47%
10.59
-32.30%
15.65
Finished Goods
12.01
-9.33%
13.25
-10.60%
14.82
+9.75%
13.50
Prepaid Assets
—
—
—
—
Assets Held For Sale Current
0.00
-100.00%
8.11
0.00
—
Other Current Assets
8.34
+32.93%
6.28
+16.13%
5.41
-23.94%
7.11
Total Non Current Assets
253.05
+9.93%
230.20
+11.23%
206.96
-18.15%
252.85
Net PPE
147.29
+9.44%
134.58
+121.26%
60.82
-3.19%
62.83
Gross PPE
296.75
+10.74%
267.98
+33.59%
200.59
-3.21%
207.24
Accumulated Depreciation
-149.46
-12.04%
-133.40
+4.56%
-139.77
+3.21%
-144.41
Properties
0.00
0.00
0.00
0.00
Land And Improvements
7.25
+13.40%
6.39
+131.15%
2.76
+8.14%
2.56
Buildings And Improvements
236.81
+23.30%
192.06
+13.98%
168.50
-4.85%
177.09
Machinery Furniture Equipment
50.21
+27.34%
39.43
+59.58%
24.71
+0.95%
24.48
Construction In Progress
1.06
-96.30%
28.71
+778.25%
3.27
+288.70%
0.84
Other Properties
1.42
+2.30%
1.39
+2.51%
1.36
-40.34%
2.27
Goodwill And Other Intangible Assets
75.37
+0.88%
74.71
+237.52%
22.14
-20.20%
27.74
Goodwill
66.48
+4.77%
63.45
+5903.12%
1.06
+2.32%
1.03
Other Intangible Assets
8.89
-21.03%
11.26
-46.59%
21.08
-21.07%
26.70
Investments And Advances
7.66
+172.45%
2.81
-94.86%
54.74
-39.01%
89.75
Long Term Equity Investment
—
0.00
-100.00%
19.49
+3.91%
18.75
Other Investments
7.66
+172.45%
2.81
-70.70%
9.60
-56.35%
21.99
Non Current Deferred Assets
1.89
-26.57%
2.57
+1037.61%
0.23
—
Non Current Deferred Taxes Assets
1.89
-26.57%
2.57
+1037.61%
0.23
—
Other Non Current Assets
—
—
0.04
-76.68%
0.19
Total Liabilities Net Minority Interest
54.18
-2.08%
55.33
+25.35%
44.14
-38.73%
72.05
Current Liabilities
48.19
-3.04%
49.70
+20.05%
41.40
-39.22%
68.12
Payables And Accrued Expenses
47.85
-1.61%
48.63
+20.67%
40.30
-39.64%
66.77
Payables
27.74
-3.72%
28.81
+18.76%
24.26
-50.11%
48.63
Accounts Payable
11.64
-31.42%
16.97
+39.93%
12.13
+8.66%
11.16
Current Accrued Expenses
20.11
+1.44%
19.82
+23.57%
16.04
-11.55%
18.14
Total Tax Payable
16.10
+36.00%
11.84
+0.69%
11.76
-68.29%
37.09
Income Tax Payable
0.00
-100.00%
0.01
-85.94%
0.06
-99.81%
32.96
Current Debt And Capital Lease Obligation
0.34
-67.12%
1.02
+3.12%
0.99
-25.26%
1.33
Current Capital Lease Obligation
0.34
-67.12%
1.02
+3.12%
0.99
-25.26%
1.33
Other Current Liabilities
—
0.04
-60.78%
0.10
+580.00%
0.01
Total Non Current Liabilities Net Minority Interest
5.99
+6.47%
5.63
+105.25%
2.74
-30.19%
3.93
Long Term Debt And Capital Lease Obligation
1.17
+18.03%
0.99
-36.31%
1.56
-38.77%
2.55
Long Term Capital Lease Obligation
1.17
+18.03%
0.99
-36.31%
1.56
-38.77%
2.55
Tradeand Other Payables Non Current
0.00
0.00
0.00
0.00
Non Current Deferred Liabilities
4.09
+14.73%
3.56
+1869.06%
0.18
0.00
Non Current Deferred Taxes Liabilities
4.09
+14.73%
3.56
+1869.06%
0.18
0.00
Stockholders Equity
1,093.90
+2.80%
1,064.06
-3.23%
1,099.57
-3.87%
1,143.88
Common Stock Equity
1,093.90
+2.80%
1,064.06
-3.23%
1,099.57
-3.87%
1,143.88
Capital Stock
662.98
-1.03%
669.88
+1.16%
662.17
+8.32%
611.32
Common Stock
662.98
-1.03%
669.88
+1.16%
662.17
+8.32%
611.32
Share Issued
381.59
-0.25%
382.53
+0.32%
381.30
+0.19%
380.58
Ordinary Shares Number
381.59
-0.25%
382.53
+0.32%
381.30
+0.19%
380.58
Additional Paid In Capital
—
—
48.45
+13.51%
42.68
Retained Earnings
447.76
-2.17%
457.71
+9.84%
416.72
-15.07%
490.68
Gains Losses Not Affecting Retained Earnings
-16.84
+73.49%
-63.52
-407.21%
20.68
+2694.48%
-0.80
Minority Interest
49.06
+4.57%
46.92
+1461.15%
-3.45
-18.01%
-2.92
Other Equity Adjustments
-16.84
+73.49%
-63.52
-407.21%
20.68
+2694.48%
-0.80
Total Equity Gross Minority Interest
1,142.96
+2.88%
1,110.98
+1.36%
1,096.12
-3.93%
1,140.96
Total Capitalization
1,093.90
+2.80%
1,064.06
-3.23%
1,099.57
-3.87%
1,143.88
Working Capital
895.90
+1.07%
886.41
-0.62%
891.91
-0.01%
892.04
Invested Capital
1,093.90
+2.80%
1,064.06
-3.23%
1,099.57
-3.87%
1,143.88
Total Debt
1.51
-25.22%
2.02
-20.96%
2.55
-34.13%
3.88
Capital Lease Obligations
1.51
-25.22%
2.02
-20.96%
2.55
-34.13%
3.88
Net Tangible Assets
1,018.53
+2.95%
989.35
-8.18%
1,077.44
-3.47%
1,116.15
Tangible Book Value
1,018.53
+2.95%
989.35
-8.18%
1,077.44
-3.47%
1,116.15
Available For Sale Securities
—
—
25.65
-47.65%
49.00
Dueto Related Parties Current
—
0.00
-100.00%
0.37
-2.86%
0.38
Dueto Related Parties Non Current
0.73
-31.69%
1.07
+6.98%
1.00
-27.48%
1.38
Investmentin Financial Assets
—
0.00
-100.00%
25.65
-47.65%
49.00
Investmentsin Associatesat Cost
—
0.00
-100.00%
19.49
+3.91%
18.75
Non Current Note Receivables
20.85
+34.27%
15.53
-77.51%
69.04
-4.57%
72.34
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
25.87
+37.27%
18.84
+143.99%
-42.84
+51.84%
-88.95
Cash Flow From Continuing Operating Activities
25.87
+37.27%
18.84
+143.99%
-42.84
+51.84%
-88.95
Net Income From Continuing Operations
-2.93
-107.32%
40.02
+153.68%
-74.55
+55.82%
-168.73
Depreciation Amortization Depletion
14.23
+52.43%
9.34
+15.12%
8.11
-38.20%
13.12
Depreciation And Amortization
14.23
+52.43%
9.34
+15.12%
8.11
-38.20%
13.12
Other Non Cash Items
1.77
+126.57%
-6.65
-245.87%
-1.92
-248.61%
1.29
Stock Based Compensation
7.05
-18.97%
8.70
-0.79%
8.77
-41.98%
15.12
Provisionand Write Offof Assets
4.86
+370.83%
1.03
+167.54%
-1.53
-130.82%
-0.66
Asset Impairment Charge
0.74
-98.25%
42.00
+56.01%
26.92
-58.51%
64.89
Operating Gains Losses
34.57
+145.91%
-75.28
-522.07%
17.84
+160.21%
-29.63
Gain Loss On Investment Securities
0.45
-88.39%
3.84
-63.46%
10.51
+132.94%
-31.91
Unrealized Gain Loss On Investment Securities
—
—
—
—
Net Foreign Currency Exchange Gain Loss
28.59
+149.41%
-57.86
-889.99%
7.32
+220.38%
2.29
Change In Working Capital
-34.41
-10965.59%
-0.31
+98.82%
-26.47
-269.03%
15.66
Change In Receivables
-25.75
-924.38%
-2.51
+61.83%
-6.59
+22.94%
-8.55
Changes In Account Receivables
-16.74
-1725.63%
-0.92
-109.96%
9.21
+439.58%
-2.71
Change In Inventory
-10.39
-240.15%
7.42
+0.24%
7.40
+202.52%
-7.22
Change In Prepaid Assets
-1.80
-251.95%
-0.51
-135.63%
1.44
+44.28%
1.00
Change In Payables And Accrued Expense
3.54
+175.20%
-4.70
+83.63%
-28.72
-194.38%
30.43
Change In Accrued Expense
2.44
-14.15%
2.84
-44.96%
5.16
+276.65%
-2.92
Change In Payable
1.10
+114.56%
-7.54
+77.74%
-33.88
-201.58%
33.35
Change In Account Payable
1.11
+114.87%
-7.45
-863.65%
-0.77
+10.43%
-0.86
Investing Cash Flow
-76.56
-143.71%
175.15
+394.37%
-59.50
-3130.13%
-1.84
Cash Flow From Continuing Investing Activities
-76.56
-143.71%
175.15
+394.37%
-59.50
-3130.13%
-1.84
Net PPE Purchase And Sale
-25.72
-107.21%
-12.41
-395.45%
-2.50
+27.41%
-3.45
Purchase Of PPE
-25.72
-107.21%
-12.41
-395.45%
-2.50
+27.41%
-3.45
Capital Expenditure
-26.06
-98.08%
-13.15
-284.28%
-3.42
+31.98%
-5.03
Net Investment Purchase And Sale
-45.11
-124.27%
185.82
+346.41%
-75.41
-2906.74%
-2.51
Purchase Of Investment
-45.11
0.00
+100.00%
-608.25
-124.13%
-271.38
Sale Of Investment
0.00
-100.00%
185.82
-65.13%
532.84
+98.18%
268.87
Net Business Purchase And Sale
0.00
-100.00%
5.99
0.00
0.00
Purchase Of Business
—
—
—
—
Net Intangibles Purchase And Sale
-0.34
+54.37%
-0.74
+19.06%
-0.92
+41.94%
-1.58
Purchase Of Intangibles
-0.34
+54.37%
-0.74
+19.06%
-0.92
+41.94%
-1.58
Net Other Investing Changes
-5.40
-53.86%
-3.51
-119.82%
17.69
+232.91%
5.31
Financing Cash Flow
-19.91
-1516.98%
-1.23
-19.51%
-1.03
+64.45%
-2.90
Cash Flow From Continuing Financing Activities
-19.91
-1516.98%
-1.23
-19.51%
-1.03
+64.45%
-2.90
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
-9.74
0.00
0.00
—
Common Stock Payments
-9.74
0.00
0.00
—
Repurchase Of Capital Stock
-9.74
0.00
0.00
—
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
-10.16
-725.67%
-1.23
-19.51%
-1.03
+64.45%
-2.90
Changes In Cash
-70.60
-136.62%
192.76
+286.49%
-103.36
-10.33%
-93.69
Effect Of Exchange Rate Changes
3.59
+210.47%
-3.25
-140.53%
8.01
+127.97%
-28.64
Beginning Cash Position
858.80
+28.32%
669.29
-12.47%
764.64
-13.79%
886.97
End Cash Position
791.79
-7.80%
858.80
+28.32%
669.29
-12.47%
764.64
Free Cash Flow
-0.19
-103.34%
5.69
+112.30%
-46.26
+50.78%
-93.98
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.10
-83.93%
0.65
-98.04%
33.01
+18551.41%
0.18
Change In Income Tax Payable
-0.01
+89.25%
-0.09
+99.72%
-33.10
-196.76%
34.21
Change In Tax Payable
-0.01
+89.25%
-0.09
+99.72%
-33.10
-196.76%
34.21
Dividends Received CFI
0.00
0.00
-100.00%
1.64
+327.60%
0.38
Earnings Losses From Equity Investments
0.00
+100.00%
-32.47
0.00
0.00
Sale Of Business
0.00
-100.00%
5.99
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category